Text size

UPDATE: Comey's testimony is finished, and it's not just the Trump-trade stocks that have headed higher.

The S&P 500 has advanced 0.2% to 2,436.85 at 12:43 p.m. today, while the Dow Jones Industrial Average has gained 63.19 points, or 0.3%, to 21,236.88, a new all-time high. The Nasdaq Composite has risen 0.2% to 6,311.37.

And those Trump-trade stocks? The Strategas basket of 30 stocks has gained 1.1%.

The verdict: The market certainly looks to be looking past Comey's testimony.

ORIGINAL POST: On the surface, the market hasn't voted one way or another on the testimony of former FBI DirectorJames Comey. But stocks connected to the so-called Trump Trade seem to be looking past the testimony and heading higher today.

JIM WATSON/AFP/Getty Images

The S&P 500 is little changed at 2,432.66 at 10:57 a.m. today, while the Dow Jones Industrial Average has advanced 16.65 point, or 0.1%, to 21,190.34. The Nasdaq Composite is little changed at 6,299.92.

Strategas Research Partners has created a basket of stocks that should do well if the policies proposed by President Donald J. Trump become reality. They include companies like Morgan Stanley (MS), which would benefit from financial deregulation, for-profit prisons operator (GEO), infrastructure-exposed companies like Emerson Electric (EMR), and defense companies like General Dynamics (GD). And that basket has gained 0.45% so far today, says Strategas Research Partners' Daniel Clifton.

In an email, Clifton chalks that up to the "he said-he said" nature of the testimony, which suggests that the President will continue to enact his policies through executive decisions, while Congress, with an eye towards 2018's mid-term election, could look to get tax and health-care reform passed by the first quarter of 2018. "Through the first hour of the proceedings, investors see no smoking gun," Clifton says. "This keeps the Trump drama as a muddle through."